Nutex Health Inc Financials
This page shows Nutex Health Inc (NUTX) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Financial Health Signals
Based on FY2024 annual data. Scores normalized against common benchmarks. How we calculate these scores
Nutex Health Inc has an operating margin of 27.2%, meaning the company retains $27 of operating profit per $100 of revenue. This strong profitability earns a score of 100/100, reflecting efficient cost management and pricing power. This is up from -12.8% the prior year.
Nutex Health Inc's revenue surged 93.8% year-over-year to $479.9M, reflecting rapid business expansion. This strong growth earns a score of 100/100.
Nutex Health Inc carries a low D/E ratio of 0.17, meaning only $0.17 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 100/100, indicating a strong balance sheet with room for future borrowing.
Nutex Health Inc's current ratio of 0.00 means current assets barely cover short-term liabilities. This tight liquidity results in a low score of 0/100, which could limit financial flexibility.
Nutex Health Inc's free cash flow margin of 4.3% results in a low score of 22/100. Capital expenditures of $2.3M absorb a large share of operating cash flow.
Nutex Health Inc earns a strong 39.3% return on equity (ROE), meaning it generates $39 of profit for every $100 of shareholders' equity. This efficient capital use earns a returns score of 100/100.
Nutex Health Inc scores 342.83, well above the 2.99 safe threshold. This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.
Nutex Health Inc passes 7 of 9 financial strength tests. 3 of 4 profitability signals pass, 2 of 3 leverage/liquidity signals pass, both operating efficiency signals pass.
For every $1 of reported earnings, Nutex Health Inc generates $0.44 in operating cash flow ($23.2M OCF vs $52.1M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.
Nutex Health Inc earns $6.6 in operating income for every $1 of interest expense ($130.7M vs $19.9M). This wide margin provides strong safety for debt servicing, even if earnings decline temporarily.
Key Financial Metrics
Nutex Health Inc generated $479.9M in revenue in fiscal year 2024. This represents an increase of 93.8% from the prior year.
Nutex Health Inc's EBITDA was $149.7M in fiscal year 2024, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 1155.3% from the prior year.
Nutex Health Inc generated $20.8M in free cash flow in fiscal year 2024, representing cash available after capex. This represents an increase of 353.0% from the prior year.
Nutex Health Inc reported $52.1M in net income in fiscal year 2024. This represents an increase of 213.8% from the prior year.
Nutex Health Inc earned $9.69 per diluted share (EPS) in fiscal year 2024. This represents an increase of 193.3% from the prior year.
Nutex Health Inc held $41K in cash against $22.5M in long-term debt as of fiscal year 2024.
Nutex Health Inc had 6M shares outstanding in fiscal year 2024. This represents an increase of 22.2% from the prior year.
Nutex Health Inc's gross margin was 40.9% in fiscal year 2024, indicating the percentage of revenue retained after direct costs. This is up 26.8 percentage points from the prior year.
Nutex Health Inc's operating margin was 27.2% in fiscal year 2024, reflecting core business profitability. This is up 40.1 percentage points from the prior year.
Nutex Health Inc's net profit margin was 10.8% in fiscal year 2024, showing the share of revenue converted to profit. This is up 29.3 percentage points from the prior year.
Nutex Health Inc's ROE was 39.3% in fiscal year 2024, measuring profit generated per dollar of shareholder equity.
Nutex Health Inc invested $2.3M in capex in fiscal year 2024, funding long-term assets and infrastructure. This represents a decrease of 75.7% from the prior year.
NUTX Income Statement
| Metric | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $267.8M+9.8% | $244.0M+15.2% | $211.8M-17.8% | $257.6M+226.9% | $78.8M+3.6% | $76.1M+12.8% | $67.5M-3.2% | $69.7M |
| Cost of Revenue | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | $154.9M+24.0% | $124.9M+5.6% | $118.3M-16.4% | $141.6M+546.2% | $21.9M-2.9% | $22.6M+122.1% | $10.2M-23.1% | $13.2M |
| R&D Expenses | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| SG&A Expenses | $11.3M-9.6% | $12.5M+24.5% | $10.0M-21.3% | $12.7M+29.2% | $9.9M-7.4% | $10.7M+23.0% | $8.7M+1.9% | $8.5M |
| Operating Income | $130.4M+287.1% | $33.7M-58.2% | $80.7M-29.4% | $114.2M+1081.9% | $9.7M+82.4% | $5.3M+265.4% | $1.4M+105.5% | -$26.1M |
| Interest Expense | $5.5M-4.0% | $5.7M-7.2% | $6.1M+21.1% | $5.1M-6.1% | $5.4M+6.5% | $5.1M+13.7% | $4.4M+4.9% | $4.2M |
| Income Tax | $27.1M+257.7% | $7.6M-62.8% | $20.4M+137.1% | $8.6M+87.8% | $4.6M+412.9% | $894K+129.2% | $390K+113.0% | -$3.0M |
| Net Income | $55.4M+413.2% | -$17.7M-183.4% | $21.2M-65.6% | $61.7M+802.0% | -$8.8M-2314.3% | -$364K0.0% | -$364K+98.8% | -$31.6M |
| EPS (Diluted) | $7.76+363.1% | $-2.95-188.6% | $3.33-70.1% | $11.12+746.5% | $-1.72-2357.1% | $-0.07 | $-0.08 | $-7.47 |
NUTX Balance Sheet
| Metric | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $964.5M+14.7% | $841.0M+10.4% | $761.9M+16.3% | $655.3M+49.4% | $438.5M+3.8% | $422.4M+4.5% | $404.3M+1.5% | $398.2M |
| Current Assets | $592.7M+25.3% | $473.0M+17.8% | $401.5M+37.3% | $292.5M+144.1% | $119.8M+5.2% | $113.9M+13.5% | $100.4M+10.5% | $90.8M |
| Cash & Equivalents | $166.0M+71.7% | $96.7M+14.2% | $84.7M+108.5% | $40.6M-13.4% | $46.9M+15.0% | $40.8M+36.0% | $30.0M+36.4% | $22.0M |
| Inventory | $3.2M+38.8% | $2.3M-27.0% | $3.1M+9.4% | $2.9M+26.2% | $2.3M-18.1% | $2.8M-7.3% | $3.0M-12.2% | $3.4M |
| Accounts Receivable | N/A | N/A | $295.1M+26.9% | $232.4M+270.5% | $62.7M+3.4% | $60.7M-1.4% | $61.5M+5.0% | $58.6M |
| Goodwill | $13.9M0.0% | $13.9M0.0% | $13.9M0.0% | $13.9M0.0% | $13.9M0.0% | $13.9M-18.4% | $17.1M0.0% | $17.1M |
| Total Liabilities | $526.5M+4.4% | $504.2M-0.5% | $506.6M+8.5% | $466.8M+30.1% | $358.7M+5.4% | $340.4M+5.0% | $324.3M+1.6% | $319.1M |
| Current Liabilities | $185.5M-4.8% | $194.9M-0.7% | $196.2M+27.2% | $154.2M+128.3% | $67.6M-5.7% | $71.7M+19.7% | $59.9M+2.7% | $58.3M |
| Long-Term Debt | $25.6M+25.0% | $20.5M-5.8% | $21.7M-3.3% | $22.5M-16.2% | $26.8M+19.6% | $22.4M-14.8% | $26.3M0.0% | $26.3M |
| Total Equity | $317.2M+34.8% | $235.3M+32.9% | $176.9M+33.6% | $132.4M+119.1% | $60.4M-3.7% | $62.7M-0.5% | $63.0M+2.5% | $61.5M |
| Retained Earnings | -$298.0M+15.7% | -$353.5M-5.3% | -$335.8M+5.9% | -$357.0M+14.7% | -$418.6M-2.1% | -$409.8M-0.1% | -$409.4M-0.1% | -$409.1M |
NUTX Cash Flow Statement
| Metric | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $99.5M+265.1% | $27.3M-46.5% | $51.0M+92889.9% | $55K-99.2% | $6.8M-48.8% | $13.3M+334.6% | $3.1M+271.8% | -$1.8M |
| Capital Expenditures | $302K-59.8% | $751K+1073.4% | $64K-83.8% | $395K-36.0% | $617K+10.4% | $559K-23.7% | $733K | N/A |
| Free Cash Flow | $99.2M+274.3% | $26.5M-47.9% | $50.9M+15066.9% | -$340K-105.5% | $6.2M-51.4% | $12.7M+447.9% | $2.3M | N/A |
| Investing Cash Flow | -$302K-254.1% | $196K+406.3% | -$64K+98.1% | -$3.3M-1149.4% | -$267K+79.0% | -$1.3M-73.3% | -$733K-184.7% | $866K |
| Financing Cash Flow | -$29.9M-93.5% | -$15.4M-126.8% | -$6.8M-128.1% | -$3.0M-609.3% | -$421K+64.6% | -$1.2M-120.9% | $5.7M+245.3% | -$3.9M |
| Dividends Paid | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
NUTX Financial Ratios
| Metric | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 57.8%+6.6pp | 51.2%-4.7pp | 55.9%+0.9pp | 55.0%+27.2pp | 27.8%-1.8pp | 29.6%+14.6pp | 15.1%-3.9pp | 19.0% |
| Operating Margin | 48.7%+34.9pp | 13.8%-24.3pp | 38.1%-6.2pp | 44.3%+32.1pp | 12.3%+5.3pp | 7.0%+4.8pp | 2.1%+39.7pp | -37.5% |
| Net Margin | 20.7%+27.9pp | -7.2%-17.3pp | 10.0%-13.9pp | 23.9%+35.1pp | -11.2%-10.7pp | -0.5%+0.1pp | -0.5%+44.8pp | -45.4% |
| Return on Equity | 17.5% | N/A | 12.0%-34.6pp | 46.6% | N/A | N/A | N/A | N/A |
| Return on Assets | 5.8%+7.8pp | -2.1%-4.9pp | 2.8%-6.6pp | 9.4%+11.4pp | -2.0%-1.9pp | -0.1%0.0pp | -0.1%+7.8pp | -7.9% |
| Current Ratio | 3.20+0.8 | 2.43+0.4 | 2.05+0.2 | 1.90+0.1 | 1.77+0.2 | 1.59-0.1 | 1.68+0.1 | 1.56 |
| Debt-to-Equity | 0.080.0 | 0.09-0.0 | 0.12-0.0 | 0.17-0.3 | 0.44+0.1 | 0.36-0.1 | 0.42-0.0 | 0.43 |
| FCF Margin | 37.0%+26.2pp | 10.9%-13.2pp | 24.0%+24.2pp | -0.1%-8.0pp | 7.8%-8.9pp | 16.7%+13.3pp | 3.4% | N/A |
Note: The current ratio is below 1.0 (0.00), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.
Similar Companies
Frequently Asked Questions
What is Nutex Health Inc's annual revenue?
Nutex Health Inc (NUTX) reported $479.9M in total revenue for fiscal year 2024. This represents a 93.8% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Nutex Health Inc's revenue growing?
Nutex Health Inc (NUTX) revenue grew by 93.8% year-over-year, from $247.6M to $479.9M in fiscal year 2024.
Is Nutex Health Inc profitable?
Yes, Nutex Health Inc (NUTX) reported a net income of $52.1M in fiscal year 2024, with a net profit margin of 10.8%.
What is Nutex Health Inc's earnings per share (EPS)?
Nutex Health Inc (NUTX) reported diluted earnings per share of $9.69 for fiscal year 2024. This represents a 193.3% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.
What is Nutex Health Inc's EBITDA?
Nutex Health Inc (NUTX) had EBITDA of $149.7M in fiscal year 2024, measuring earnings before interest, taxes, depreciation, and amortization.
How much debt does Nutex Health Inc have?
As of fiscal year 2024, Nutex Health Inc (NUTX) had $41K in cash and equivalents against $22.5M in long-term debt.
What is Nutex Health Inc's gross margin?
Nutex Health Inc (NUTX) had a gross margin of 40.9% in fiscal year 2024, indicating the percentage of revenue retained after direct costs of goods sold.
What is Nutex Health Inc's operating margin?
Nutex Health Inc (NUTX) had an operating margin of 27.2% in fiscal year 2024, reflecting the profitability of core business operations before interest and taxes.
What is Nutex Health Inc's net profit margin?
Nutex Health Inc (NUTX) had a net profit margin of 10.8% in fiscal year 2024, representing the share of revenue converted into profit after all expenses.
What is Nutex Health Inc's return on equity (ROE)?
Nutex Health Inc (NUTX) has a return on equity of 39.3% for fiscal year 2024, measuring how efficiently the company generates profit from shareholder equity.
What is Nutex Health Inc's free cash flow?
Nutex Health Inc (NUTX) generated $20.8M in free cash flow during fiscal year 2024. This represents a 353.0% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Nutex Health Inc's operating cash flow?
Nutex Health Inc (NUTX) generated $23.2M in operating cash flow during fiscal year 2024, representing cash generated from core business activities.
What are Nutex Health Inc's total assets?
Nutex Health Inc (NUTX) had $655K in total assets as of fiscal year 2024, including both current and long-term assets.
What are Nutex Health Inc's capital expenditures?
Nutex Health Inc (NUTX) invested $2.3M in capital expenditures during fiscal year 2024, funding long-term assets and infrastructure.
How many shares does Nutex Health Inc have outstanding?
Nutex Health Inc (NUTX) had 6M shares outstanding as of fiscal year 2024.
What is Nutex Health Inc's current ratio?
Nutex Health Inc (NUTX) had a current ratio of 0.00 as of fiscal year 2024, which is below 1.0, which may suggest potential liquidity concerns.
What is Nutex Health Inc's debt-to-equity ratio?
Nutex Health Inc (NUTX) had a debt-to-equity ratio of 0.17 as of fiscal year 2024, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Nutex Health Inc's return on assets (ROA)?
Nutex Health Inc (NUTX) had a return on assets of 7949.7% for fiscal year 2024, measuring how efficiently the company uses its assets to generate profit.
What is Nutex Health Inc's Altman Z-Score?
Nutex Health Inc (NUTX) has an Altman Z-Score of 342.83, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios—working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets—to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is Nutex Health Inc's Piotroski F-Score?
Nutex Health Inc (NUTX) has a Piotroski F-Score of 7 out of 9, indicating strong financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Nutex Health Inc's earnings high quality?
Nutex Health Inc (NUTX) has an earnings quality ratio of 0.44x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Nutex Health Inc cover its interest payments?
Nutex Health Inc (NUTX) has an interest coverage ratio of 6.6x, meaning it can comfortably cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is Nutex Health Inc?
Nutex Health Inc (NUTX) scores 70 out of 100 on our Financial Profile, indicating strong overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.